CARE Ratings · NSE: CARERATING · BSE: 534804

Q2 FY25 results · Jul–Sep 2024

CARE Ratings reported revenue from operations of ₹117.37 crore (up 21.7% from Q2 FY24) and net profit of ₹46.88 crore (up 31.2% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY25Q2 FY24YoYQ1 FY25QoQ
Revenue from operations117.3796.44+21.7%78.92+48.7%
Other income11.8611.19+6.0%11.87−0.1%
Total income129.23107.63+20.1%90.79+42.3%
Profit before tax64.2350.06+28.3%30.43+111.1%
Net profit for the period46.8835.73+31.2%21.38+119.2%
Attributable to shareholders of the company46.0935.17+31.0%20.73+122.3%
EPS, basic (₹)15.4111.83+30.3%6.94+122.2%
Net margin (%)39.937.127.1
Standalone · ₹ crore
ItemQ2 FY25Q2 FY24YoYQ1 FY25QoQ
Revenue from operations101.5185.11+19.3%65.34+55.3%
Other income11.7611.51+2.1%12.69−7.4%
Total income113.2796.62+17.2%78.04+45.1%
Profit before tax66.2954.61+21.4%32.48+104.1%
Net profit for the period49.6440.75+21.8%24.01+106.7%
EPS, basic (₹)16.6013.71+21.1%8.04+106.6%
Net margin (%)48.947.936.7
Consolidated
Filed with BSE
25 Oct 2024, 15:16 IST
Board meeting
23 Oct 2024
Period
01 Jul 2024 to 30 Sep 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
25 Oct 2024, 15:16 IST
Board meeting
23 Oct 2024
Period
01 Jul 2024 to 30 Sep 2024
Review status
Unaudited
Source
XBRL filing on BSE